国际标准期刊号: 2329-9053

分子药剂学与有机过程研究杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • 学术钥匙
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Changes in Erythropoiesis in Type 3 Hemochromatosis Mouse Models

Ramos Sousa

Type 3 haemochromatosis is a rare inherited iron excess condition that results in organ dysfunction. Mutations in the transferrin receptor 2 gene, which codes for two major isoforms, cause HFE3. Tfr2 is a hepatic regulator of the iron inhibitor hepcidin. Tfr2 is an intracellular isoform of the protein that controls iron levels in reticuloendothelial cells. Tfr2 is also important in erythropoiesis, as recently revealed. Tfr2 deficiency causes macrocytosis with reduced reticulocyte number and higher haemoglobin levels, as well as an increase in adult BM erythropoiesis and splenic erythropoiesis. Tfr2 deficiency, on the other hand, results in enhanced and immature splenic erythropoiesis. Taken together, our findings support the involvement of Tfr2 in erythropoiesis regulation and Tfr2 in promoting iron availability for erythropoiesis.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。